中国医药: 关于中国医药健康产业股份有限公司2025年第五次临时股东大会的法律意见书

Group 1 - The legal opinion letter confirms that the procedures for convening and holding the shareholder meeting comply with the Company Law, Shareholder Meeting Rules, and the company's articles of association [2][3][6] - The shareholder meeting is scheduled for August 8, 2025, with both on-site and online voting options available [2][3] - The total number of shares represented at the meeting was 648,953,202 shares from on-site participants and 13,190,318 shares from online voters, accounting for 44.2644% of the total voting shares [4][5] Group 2 - The voting results showed that 658,792,760 shares were in favor of the proposals, representing 99.4939% of the valid votes cast [5][6] - The small and medium-sized investors' votes indicated that 30,490,912 shares were in favor, which is 90.0987% of the valid votes from this group [5][6] - The legal opinion concludes that the voting methods and results are valid and comply with relevant laws and regulations [6]